LivaNova Plc (LIVN)
66.56
+1.53
(+2.35%)
USD |
NASDAQ |
Feb 06, 16:00
66.57
+0.01
(+0.02%)
After-Hours: 20:00
LivaNova SG&A Expense (TTM) : 545.57M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NovoCure Ltd. | 445.94M |
| Abbott Laboratories | 12.33B |
| Alphatec Holdings, Inc. | 484.37M |
| AtriCure, Inc. | 304.86M |
| iRhythm Holdings, Inc. | 470.32M |